- Home
- EMA vs ASND Comparison
EMA vs ASND Comparison
Compare EMA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMA
- ASND
- Stock Information
- Founded
- EMA 1998
- ASND 2006
- Country
- EMA Canada
- ASND Denmark
- Employees
- EMA N/A
- ASND N/A
- Industry
- EMA Electric Utilities: Central
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- EMA Utilities
- ASND Health Care
- Exchange
- EMA Nasdaq
- ASND Nasdaq
- Market Cap
- EMA 14.3B
- ASND 12.0B
- IPO Year
- EMA N/A
- ASND 2015
- Fundamental
- Price
- EMA $47.86
- ASND $204.05
- Analyst Decision
- EMA Hold
- ASND Strong Buy
- Analyst Count
- EMA 1
- ASND 16
- Target Price
- EMA $68.00
- ASND $240.75
- AVG Volume (30 Days)
- EMA 146.5K
- ASND 401.5K
- Earning Date
- EMA 01-01-0001
- ASND 11-13-2025
- Dividend Yield
- EMA 4.32%
- ASND N/A
- EPS Growth
- EMA 15.04
- ASND N/A
- EPS
- EMA 2.18
- ASND N/A
- Revenue
- EMA $6,033,610,485.00
- ASND $576,332,355.00
- Revenue This Year
- EMA $21.63
- ASND $102.31
- Revenue Next Year
- EMA N/A
- ASND $76.44
- P/E Ratio
- EMA $22.32
- ASND N/A
- Revenue Growth
- EMA 12.01
- ASND 54.50
- 52 Week Low
- EMA $43.90
- ASND $118.03
- 52 Week High
- EMA $49.01
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- EMA 60.65
- ASND 60.82
- Support Level
- EMA $47.40
- ASND $187.25
- Resistance Level
- EMA $48.35
- ASND $205.48
- Average True Range (ATR)
- EMA 0.53
- ASND 5.42
- MACD
- EMA 0.17
- ASND 0.41
- Stochastic Oscillator
- EMA 80.23
- ASND 92.16
About EMA Emera Incorporated Common Shares
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.